Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Completed1
Enrolling By Invitation1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT03655223Enrolling By Invitation

Early Check: Expanded Screening in Newborns

NCT05910151Unknown

Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan

NCT00983788Phase 2CompletedPrimary

Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects

Showing all 3 trials

Research Network

Activity Timeline